<DOC>
	<DOCNO>NCT01566604</DOCNO>
	<brief_summary>This study ass efficacy safety once-daily , 50µg inhalation NVA237 moderate severe chronic obstructive pulmonary disease ( COPD ) patient 26 week treatment .</brief_summary>
	<brief_title>Efficacy , Safety Tolerability NVA237 Patients With Chronic Obstructive Pulmonary Disease</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Glycopyrrolate</mesh_term>
	<criteria>Male female adult age ≥40 year , sign Informed Consent Form prior initiation studyrelated procedure With moderate severe stable COPD ( Stage II Stage III ) . Current exsmokers smoke history least 10 pack year ( Ten pack year define 20 cigarette day 10 year , 10 cigarette day 20 year ) . Postbronchodilator FEV1 ≥30 % &lt; 80 % predict normal , postbronchodilator FEV1/FVC &lt; 0.7 Visit 2 ( Day 14 ) ( post mean : record FEV1 FVC 45 min administer ipratropium ) . Symptomatic patient , accord daily electronic diary data Visit 2 ( Day 14 ) Visit 3 ( Day 1 ) , total score 1 least 4 last 7 day prior Visit 3 With history malignancy organ system ( include lung cancer ) , treat untreated , within past 5 year whether evidence local recurrence metastasis , exception localize basal cell carcinoma skin . Patients history asthma indicate ( limited ) blood eosinophil count &gt; 600/mm3 ( Visit 2 ) onset symptom prior age 40 year . Patients without asthma blood eosinophil count &gt; 600/mm3 Visit 2 exclude . Patients concomitant pulmonary disease , e.g . pulmonary tuberculosis ( unless confirm imaging longer active ) clinically significant bronchiectasis , sarcoidosis interstitial lung disorder . Patients lung lobectomy lung volume reduction lung transplantation . Patients known history diagnosis α1 antitrypsin deficiency . Patients COPD exacerbation require treatment antibiotic , systemic steroid ( oral intravenous ) hospitalization 6 week prior Visit 1 Patients respiratory tract infection within 6 week prior Visit 1 . Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Chronic obstructive pulmonary disease ( COPD )</keyword>
	<keyword>NVA237</keyword>
</DOC>